{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:13:57Z","timestamp":1774890837735,"version":"3.50.1"},"reference-count":148,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1517\/14740338.1.4.355","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T11:30:48Z","timestamp":1115206248000},"page":"355-364","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacotherapy of gastro-oesophageal reflux disease in children: focus on safety"],"prefix":"10.1517","volume":"1","author":[{"given":"Yvan","family":"Vandenplas","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Academic Hospital, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hegar","family":"Badriul","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Academic Hospital, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Salvatore","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Academic Hospital, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Academic Hospital, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"e_1_2_1_3_1","unstructured":"DORLOCHTER L KOLSRUD E OLAFSDOTTIR E FLUGE G ROSENDAHL K HATLEBAKK J: [Oesophageal stricture as a complication of gastroesophageal reflux in children]. Tidsskr. Nor Laegeforen. (2000) 120:187-189. Norwegian."},{"key":"e_1_2_1_4_1","first-page":"5","article-title":"GERD warrants increased physician appreciation and improved treatment","volume":"10","author":"WEBB D","year":"2001","unstructured":"WEBB D: GERD warrants increased physician appreciation and improved treatment. Postgrad. Med. (2001) 10:5\u201310.","journal-title":"Postgrad. Med."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430070055030"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"ENCK P DUBOIS D MARQUIS P: Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic\/International Gastrointestinal Surveillance Study (DIGEST). Scand. Gastroenterol. (1999) 231(Suppl.):548\u2013554.","DOI":"10.1080\/003655299750025264"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-6465(22)02441-0"},{"key":"e_1_2_1_8_1","first-page":"607","article-title":"Reflux symptoms in 100 normal infants: diagnostic validity of the Infant Gastroesophageal Reflux Questionnaire","volume":"35","author":"ORENSTEIN SR","year":"1996","unstructured":"ORENSTEIN SR, SHALABY TM, COHN J: Reflux symptoms in 100 normal infants: diagnostic validity of the Infant Gastroesophageal Reflux Questionnaire. Pediatr. (1996) 35:607\u2013614.","journal-title":"Pediatr"},{"key":"e_1_2_1_9_1","unstructured":"\u2022\u2022 The only questionnaire available that attempted to evaluate the sensitivity and specificity of a questionnaire to diagnose reflux in infants."},{"key":"e_1_2_1_10_1","unstructured":"CHOUHOU D ROSSIGNOL C BERNARD F: [Gastroesophageal reflux in screening centers in children under 4 years of age]. Arch. Franc. Padiatr. (1992) 49:843-845. French."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1997.02170430035007"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.6.e67"},{"key":"e_1_2_1_13_1","unstructured":"\u2022\u2022The best data available on the naturalcourse of symptoms of GOR in infancy."},{"key":"e_1_2_1_14_1","first-page":"7","article-title":"Epidemiology of reflux disease and reflux esophagitis","volume":"24","author":"WIENBECK M","year":"1989","unstructured":"WIENBECK M, BARNERT J: Epidemiology of reflux disease and reflux esophagitis. Land. j Gastroenterol (1989) 24:7\u201313.","journal-title":"Land. j Gastroenterol"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.1999.00442.x"},{"key":"e_1_2_1_16_1","unstructured":"\u2022This study provides information on the long-term efficacy of medical treatment of reflux disease in young children with untreated reflux."},{"key":"e_1_2_1_17_1","first-page":"22","article-title":"Gastroesophageal reflux disease in children older than two years of age","volume":"94","author":"TOLAYMAT N","year":"1998","unstructured":"TOLAYMAT N, CHAPMAN DM: Gastroesophageal reflux disease in children older than two years of age. W V Med. (1998) 94:22\u201325.","journal-title":"W V Med."},{"key":"e_1_2_1_18_1","first-page":"435","article-title":"Gastroesophageal reflux in the older child: presentation, response to treatment, and long-term follow-up","volume":"30","author":"TREEM W","year":"1991","unstructured":"TREEM W, DAVIS P, HYAMS J: Gastroesophageal reflux in the older child: presentation, response to treatment, and long-term follow-up. OM. Pediatr. (1991) 30:435\u2013440.","journal-title":"OM. Pediatr."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096056"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2000.0122"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7315.736"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000007730"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.4.481"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.34.176.344"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012010-00024"},{"key":"e_1_2_1_26_1","first-page":"282","article-title":"Adenocarcinoma in childhood Barrett's esophagus: case documentation and the need for surveillance in children","volume":"88","author":"HASSALL E","year":"1993","unstructured":"HASSALL E, DIMMICK JE, MAGEE JF: Adenocarcinoma in childhood Barrett's esophagus: case documentation and the need for surveillance in children. Am. Gastroenterol (1993) 88:282\u2013288.","journal-title":"Am. Gastroenterol"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199709000-00003"},{"key":"e_1_2_1_28_1","unstructured":"\u2022The author reviews the risk factors for Barrett's oesophagus in children."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352846"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.1423_c.x"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90417-7"},{"key":"e_1_2_1_32_1","first-page":"81","article-title":"Clinical epidemiology and natural history of gastroesophageal reflux disease","volume":"72","author":"SONNENBERG A","year":"1999","unstructured":"SONNENBERG A, EL-SERAG HB: Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale j Biol. Med. (1999) 72:81\u201392.","journal-title":"Yale j Biol. Med."},{"key":"e_1_2_1_33_1","first-page":"350","article-title":"Adverse events of HP eradication: long term negative consequences of HP eradication","volume":"61","author":"DE KOSTER E","year":"1998","unstructured":"DE KOSTER E: Adverse events of HP eradication: long term negative consequences of HP eradication. Acta Gastroenterol Belg. (1998) 61:350\u2013351.","journal-title":"Acta Gastroenterol Belg."},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_1_35_1","first-page":"42","article-title":"Gastroesophageal reflux disease","volume":"110","author":"KAYANRD A","year":"2001","unstructured":"KAYANRD A, FLORA K: Gastroesophageal reflux disease. Control of symptoms, prevention of complications. Postgrad. Med. (2001) 110:42\u201344.","journal-title":"Control of symptoms, prevention of complications. Postgrad. Med."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050613"},{"key":"e_1_2_1_37_1","unstructured":"\u2022A European paediatric consensus on guidelines for infant regurgitation."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.81.3.F201"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200011000-00018"},{"key":"e_1_2_1_40_1","unstructured":"\u2022Although the number of included patients is small the paper shows that volume reduction results in a decrease of regurgitation and emesis but not in a change of pH-metry criteria."},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.156.2.109"},{"key":"e_1_2_1_42_1","unstructured":"\u2022Many conservative measures commonly used to treat GOR disease in infants have no proven efficacy. Although thickened formulas do not appear to reduce measurable reflux they may reduce vomiting."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200004000-00005"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200205000-00003"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199810000-00011"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200009000-00040"},{"key":"e_1_2_1_47_1","unstructured":"CINQUETTI M BONETTI P BERTAMINI P: Current role of"},{"key":"e_1_2_1_48_1","unstructured":"\u2022\u2022 antidopaminergic drugs in pediatrics. Pedlar': Med. ChM (2000) 22:1\u20137."},{"key":"e_1_2_1_49_1","first-page":"805","article-title":"Torsade de pointes induced by metoclopramide in an elderly woman with preexisting complete left bundle branch block","volume":"4","author":"CHOU CC","year":"2001","unstructured":"CHOU CC, WU D: Torsade de pointes induced by metoclopramide in an elderly woman with preexisting complete left bundle branch block. Chang Cubrig Med. (2001) 4:805\u2013809.","journal-title":"Chang Cubrig Med."},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00456.x"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18003"},{"key":"e_1_2_1_52_1","first-page":"976","article-title":"The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis","volume":"92","author":"SOYKAN I","year":"1997","unstructured":"SOYKAN I, SAOSIEK I, MCCALLUM RW: The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am. j Castroenterol (1997) 92:976\u2013980.","journal-title":"Am. j Castroenterol"},{"key":"e_1_2_1_53_1","unstructured":"LU F WU H ZHANG K LI D: [Domperidone and hyperprolactinemia]. Human Yi Ke Da Xue Xue Bao (1998) 23:100-102. Chinese."},{"key":"e_1_2_1_54_1","first-page":"545","article-title":"QT interval and ventricular fibrillation with iv","volume":"70","author":"BRUERA E","year":"1986","unstructured":"BRUERA E, VILLAMAYOR R, ROCA E, BARUGEL M, TRONGE J, CHACON R: QT interval and ventricular fibrillation with iv. domperidone. Cancer Treat. Rep. (1986) 70:545\u2013546.","journal-title":"domperidone. Cancer Treat. Rep."},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.16.1883"},{"key":"e_1_2_1_56_1","unstructured":"\u2022This paper documents that QT-prolongation occurs with other prokinetics as well as with cisapride."},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/096032718500400608"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6462.160-c"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92959-9"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92515-2"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6458.1579"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90841-9"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92016-5"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.117577"},{"key":"e_1_2_1_65_1","unstructured":"\u2022\u2022Erythromycin in young infants or in theirmother during (late) pregnancy is a risk factor for pyloric stenosis."},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","unstructured":"BRIXIUS B LINDINGER A BAGHAI A LIMBACH HG HOFFMANN W: [Ventricular tachycardia after erythromycin administration in a newborn with congenital AV-block]. Kiln. Padiatr. (1999) 211:465-468. German.","DOI":"10.1055\/s-2008-1043836"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.4.983"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.1.301"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1086\/315853"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199905000-00017"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200011000-00006"},{"key":"e_1_2_1_72_1","unstructured":"\u2022The most recent published paediatric guidelines regarding cisapride use."},{"key":"e_1_2_1_73_1","first-page":"1","article-title":"Clinical and endoscopic evaluation of the efficacy of cisapride as compared to metoclopramide in gastroesophageal reflux in children","volume":"19","author":"GONZALES GALICIA JA","year":"1992","unstructured":"GONZALES GALICIA JA, JUAREZ GALINDO S, SUARIZ MORAN E: Clinical and endoscopic evaluation of the efficacy of cisapride as compared to metoclopramide in gastroesophageal reflux in children. Invest. Med. Int. (1992) 19:1\u20138.","journal-title":"Invest. Med. Int."},{"key":"e_1_2_1_74_1","first-page":"3","article-title":"Comparative study between cisapride and metoclopramide in newborns with gastroesophageal reflux","volume":"22","author":"BRAVO MATUS CA","year":"1995","unstructured":"BRAVO MATUS CA, FLORES RM: Comparative study between cisapride and metoclopramide in newborns with gastroesophageal reflux. Invest. Med. Int. (1995) 22:3\u20137.","journal-title":"Invest. Med. Int."},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(87)80592-4"},{"key":"e_1_2_1_76_1","first-page":"243","article-title":"Cisapride or metoclopramide to accelerate small bowel transit during barium follow-through examination? Abdom","volume":"25","author":"HARE C","year":"2000","unstructured":"HARE C, HALLIGAN S, BARTRAM CI, PLATT K, RALEIGH G: Cisapride or metoclopramide to accelerate small bowel transit during barium follow-through examination? Abdom. Imaging (2000) 25:243\u2013245.","journal-title":"Imaging"},{"key":"e_1_2_1_77_1","unstructured":"AUGOOD C MACLENNAN S GILBERT R LOGAN S: Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst. Rev (2000) 3:CD002300."},{"key":"e_1_2_1_78_1","unstructured":"\u2022The authors question the efficacy of cisapride but conclude also that cisapride reduces the reflux index."},{"key":"e_1_2_1_79_1","first-page":"395","article-title":"Report from the NASPGN therapeutics subcommittee","volume":"23","author":"SHULMAN RJ","year":"1996","unstructured":"SHULMAN RJ: Report from the NASPGN therapeutics subcommittee. Cisapride and the attack of the P450s. j Pediatr. Catsroenterol Num. (1996) 23:395\u2013397.","journal-title":"Cisapride and the attack of the P450s. j Pediatr. Catsroenterol Num."},{"key":"e_1_2_1_80_1","unstructured":"\u2022The point of view of the North American Society of Pediatric Gastroenterology and Nutrition on the safety of cisapride."},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15349-4"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02107-8"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00655.x"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.79.2.F110"},{"key":"e_1_2_1_85_1","unstructured":"WAYHS ML BARROS JP SILVA ML FERNANDES VR LOPES SL: The QT interval in children receiving cisapride. I Pediatr. Castroenterol Nutr. (2000) 31\\(Suppl. 2):S247\u2013S248."},{"key":"e_1_2_1_86_1","unstructured":"ALONSO E AL-TAWIL YS SIMAKAJOMBOON R NOEL RA: Evaluation of QTc changes in pediatric patients treated with cisapride. j Pediatr. Castroenterol Nutr. (2000) 31\\(Suppl. 2):S35."},{"key":"e_1_2_1_87_1","doi-asserted-by":"crossref","unstructured":"LEVINE A FOGELMAN R SIROTA L ZANGEN Z SHAMIR R DINARI G: QT interval in children and infants receiving cisapride. Pediatrics (1998) 101:E9. Abstract.","DOI":"10.1542\/peds.101.3.e9"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.79.6.469"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.6.1053"},{"key":"e_1_2_1_90_1","first-page":"542","volume":"64","author":"VAN HAARST AD","year":"1998","unstructured":"VAN HAARST AD, VAN T KLOOSTER GA, VAN GERVEN JM et al.: The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin. Pharmacol Ther. (1998) 64:542\u2013546.","journal-title":"GERVEN JM et al.: The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin. Pharmacol Ther."},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.2.469"},{"key":"e_1_2_1_92_1","unstructured":"LEVY J HAYES C KERN J et al.: Does cisapride influence cardiac rhythm? Results of a US multicenter double-blind placebo controlled pediatric study. I Pediatr. Castroenterol Nutr. (2000) 31\\(Suppl. 2):S100."},{"key":"e_1_2_1_93_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0987-7983(98)80161-8","article-title":"Prepulsid et allongement de l'espace QT","volume":"11","author":"TAHIRI C","year":"1998","unstructured":"TAHIRI C: Prepulsid et allongement de l'espace QT. 1. P\u00e9diatr. Pu\u00e9riculture (1998) 11:422\u2013428.","journal-title":"1. P\u00e9diatr. Pu\u00e9riculture"},{"key":"e_1_2_1_94_1","doi-asserted-by":"crossref","unstructured":"HANSON R BROWNE G FASHER B MCASKILL M MORONEY P HAWKER R: Cisapride-prolonged QT-interval: too much of a good thing! I Pediatr. (1997) 130:164\u2013166.","DOI":"10.1016\/S0022-3476(97)70337-8"},{"key":"e_1_2_1_95_1","first-page":"509","volume":"4","author":"LUPOGLAZOFF JM","year":"1997","unstructured":"LUPOGLAZOFF JM, BEDU A, FAURE Cet al.: Long QST syndrome under cisapride in neonates and infants. Arch. Pediatr. (1997) 4:509\u2013514.","journal-title":"FAURE Cet al.: Long QST syndrome under cisapride in neonates and infants. Arch. Pediatr."},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2000.tb18257.x"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/fn.84.1.F44"},{"key":"e_1_2_1_98_1","first-page":"41","article-title":"QTc interval in infants and serum concentrations","volume":"33","author":"BENATAR A","year":"2001","unstructured":"BENATAR A, FEENSTRA A, DE CRAENE T, VANDENPLAS Y: QTc interval in infants and serum concentrations. Pediatr GartroeMeroL Nub: (2001) 33:41\u201346.","journal-title":"Pediatr GartroeMeroL Nub"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)70007-X"},{"key":"e_1_2_1_100_1","first-page":"691","volume":"11","author":"NAPOLITANO C","year":"2000","unstructured":"NAPOLITANO C, SCHWARTZ PJ, BROWN AM etal.: Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. I Cardiovasc. Electrophysiol (2000) 11:691\u2013696.","journal-title":"BROWN AM etal.: Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. I Cardiovasc. Electrophysiol"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00241-7"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200039040-00005"},{"key":"e_1_2_1_103_1","doi-asserted-by":"crossref","unstructured":"BACHMANN KA SULLIVAN TJ JAUREGUI L REESE J MILLER K LEVINE L: Drug interactions of H2-receptor antagonists. Scan. I Castroenterol (1994) 206(Suppl.):14\u201319.","DOI":"10.3109\/00365529409091415"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01073.x"},{"key":"e_1_2_1_105_1","doi-asserted-by":"crossref","unstructured":"SABESIN SM: Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Aliment. Pharmacol. Ther (1993) 7\\(Suppl. 2):35\u201340.","DOI":"10.1111\/j.1365-2036.1993.tb00597.x"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199410000-00002"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200106000-00021"},{"key":"e_1_2_1_108_1","first-page":"335","article-title":"Lethargy in the course of treatment with ranitidine in a newborn infant","volume":"48","author":"DUBOIS A","year":"1993","unstructured":"DUBOIS A, BROUSSINE L, BLAYO M, RICHE C: Lethargy in the course of treatment with ranitidine in a newborn infant. Pediatric. (1993) 48:335\u2013336.","journal-title":"Pediatric."},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.25211"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314801"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01957535"},{"key":"e_1_2_1_112_1","first-page":"1","article-title":"Histamine 2 receptor blocker-ranitidine and sinus mode dysfunction","volume":"60","author":"HU WH","year":"1997","unstructured":"HU WH, WANG KY, HWANG DS, TING CT, WU TC: Histamine 2 receptor blocker-ranitidine and sinus mode dysfunction. Zhorighua Yi Xue Za Zhi (1997) 60:1\u20135.","journal-title":"Zhorighua Yi Xue Za Zhi"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200202000-00018"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02482297"},{"key":"e_1_2_1_115_1","unstructured":"\u2022The effect of Hz-blockers on heart rate."},{"key":"e_1_2_1_116_1","first-page":"23","article-title":"Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora","volume":"237","author":"BASIT AW","year":"2002","unstructured":"BASIT AW, NEWATON JM, LACEY LF: Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora. bit.j Pharm. (2002) 237:23\u201333.","journal-title":"bit.j Pharm."},{"key":"e_1_2_1_117_1","first-page":"383","article-title":"Alteration of normal gastric flora in neonates receiving ranitidine","volume":"17","author":"COTHRAN DS","year":"1997","unstructured":"COTHRAN DS, BOROWITZ SM, SUTPHEN JL, DUDLEY SM, DON OWITZ LG: Alteration of normal gastric flora in neonates receiving ranitidine. 1. Perinatal (1997) 17:383\u2013388.","journal-title":"1. Perinatal"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7269.1103"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0184"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00575.x"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01024.x"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00985.x"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80100-4"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631020-00002"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80018-7"},{"key":"e_1_2_1_126_1","unstructured":"\u2022\u2022A good overview on the use of PPIs inchildren."},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00214.x"},{"key":"e_1_2_1_128_1","unstructured":"CASTOT A BIDAULT I DAHAN R EFTHYMIOU ML: [Evaluation of unexpected and toxic effects of omeprazole A90 reported to the regional centers of pharmacovigilance during the first 22 postmarketing months]. Therapie (1993) 48:469-474. French."},{"key":"e_1_2_1_129_1","unstructured":"BERARDI RR: Proton pump inhibition. An effective safe approach to GERD management. Postgrad. Med. (2001) Spec. No:24-35."},{"key":"e_1_2_1_130_1","first-page":"523","article-title":"ROHSS K: Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole","volume":"40","author":"ANDERSSON T","year":"2001","unstructured":"ANDERSSON T, HANSSAN-ALIN M, HASSELGREN G, ROHSS K: Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole. Pharmacy\/dna. (2001) 40:523\u2013537.","journal-title":"Pharmacy\/dna."},{"issue":"342","key":"e_1_2_1_131_1","volume":"33","author":"TER HEIDE H","year":"2001","unstructured":"TER HEIDE H, HENDRIKS HJ, HEIJMANS H et al.: Are children with cystic fibrosis who are treated with a proton- pump inhibitor at risk for vitamin B12 deficiency? I Pediati: Gast\/venter-a Nutr. (2001) 33:342-345.","journal-title":"Are children with cystic fibrosis who are treated with a proton- pump inhibitor at risk for vitamin B12 deficiency? I Pediati: Gast\/venter-a Nutr"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v6.i6.789"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2000.00312.x"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128072-200103060-00007"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00685516"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00868.x"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199709000-00018"},{"key":"e_1_2_1_138_1","first-page":"G867\u2013G874","article-title":"Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists","volume":"277","author":"BLACKSHAW LA","year":"1999","unstructured":"BLACKSHAW LA, STAUNTON E, LEHMANN A, DENT J: Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists. Am. I Physiol (1999) 277:G867\u2013G874.","journal-title":"Am. I Physiol"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70408-2"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.02328.x"},{"key":"e_1_2_1_141_1","first-page":"55","article-title":"Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature","volume":"54","author":"GUY C","year":"1999","unstructured":"GUY C, OLLAGNIER M: Sucralfate and bezoars: data from the system of pharmacologic vigilance and review of the literature. Therapie (1999) 54:55\u201358.","journal-title":"Therapie"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10117"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(99)90065-9"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(90)90756-Y"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(97)90075-1"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.3.347"},{"key":"e_1_2_1_147_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2002.02074.x"},{"key":"e_1_2_1_148_1","first-page":"259","article-title":"Function of pediatric Nissen-Rossetti fundoplication followed up into adolescence and adulthood","volume":"184","author":"BERGMEIJER JH","year":"1997","unstructured":"BERGMEIJER JH, HARBERS JS, MOLENAAR JC: Function of pediatric Nissen-Rossetti fundoplication followed up into adolescence and adulthood. j Am. Coll. Surg. (1997) 184:259\u2013261.","journal-title":"j Am. Coll. Surg."},{"key":"e_1_2_1_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004640000143"},{"key":"e_1_2_1_150_1","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2002.30862"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.1.4.355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:53:30Z","timestamp":1770944010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.1.4.355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1517\/14740338.1.4.355"],"URL":"https:\/\/doi.org\/10.1517\/14740338.1.4.355","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}